Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN4278667 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Aggrecan (ACAN) antibody
- Antibody type
- Monoclonal
- Description
- Tissue culture supernatant
- Reactivity
- Human, Mouse, Rat, Bovine, Canine, Feline, Guinea Pig, Horse, Porcine, Rabbit, Sheep
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- BC-3
- Vial size
- 0.25 mL
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Extracellular matrix-based cryogels for cartilage tissue engineering.
Immunohistochemical expression and distribution of proteoglycans and collagens in sclerocornea.
Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs.
Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.
Mechanisms involved in cartilage proteoglycan catabolism.
Han ME, Kim SH, Kim HD, Yim HG, Bencherif SA, Kim TI, Hwang NS
International journal of biological macromolecules 2016 Dec;93(Pt B):1410-1419
International journal of biological macromolecules 2016 Dec;93(Pt B):1410-1419
Immunohistochemical expression and distribution of proteoglycans and collagens in sclerocornea.
Bouhenni R, Hart M, Al-Jastaneiah S, AlKatan H, Edward DP
International ophthalmology 2013 Dec;33(6):691-700
International ophthalmology 2013 Dec;33(6):691-700
Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T, Takada T, Suzuki T, Kakutani K, Maeno K, Doita M, Kurosaka M, Nishida K
Arthritis research & therapy 2012 Mar 6;14(2):R51
Arthritis research & therapy 2012 Mar 6;14(2):R51
A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs.
Swearingen CA, Chambers MG, Lin C, Marimuthu J, Rito CJ, Carter QL, Dotzlaf J, Liu C, Chandrasekhar S, Duffin KL, Mitchell PG, Durham TB, Wiley MR, Thirunavukkarasu K
Osteoarthritis and cartilage 2010 Sep;18(9):1159-66
Osteoarthritis and cartilage 2010 Sep;18(9):1159-66
Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.
Little CB, Hughes CE, Curtis CL, Janusz MJ, Bohne R, Wang-Weigand S, Taiwo YO, Mitchell PG, Otterness IG, Flannery CR, Caterson B
Matrix biology : journal of the International Society for Matrix Biology 2002 Apr;21(3):271-88
Matrix biology : journal of the International Society for Matrix Biology 2002 Apr;21(3):271-88
Mechanisms involved in cartilage proteoglycan catabolism.
Caterson B, Flannery CR, Hughes CE, Little CB
Matrix biology : journal of the International Society for Matrix Biology 2000 Aug;19(4):333-44
Matrix biology : journal of the International Society for Matrix Biology 2000 Aug;19(4):333-44
No comments: Submit comment
No validations: Submit validation data